- Home
- FULT vs CRNX Comparison
FULT vs CRNX Comparison
Compare FULT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULT
- CRNX
- Stock Information
- Founded
- FULT 1882
- CRNX 2008
- Country
- FULT United States
- CRNX United States
- Employees
- FULT N/A
- CRNX N/A
- Industry
- FULT Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FULT Finance
- CRNX Health Care
- Exchange
- FULT Nasdaq
- CRNX Nasdaq
- Market Cap
- FULT 2.8B
- CRNX 2.8B
- IPO Year
- FULT N/A
- CRNX 2018
- Fundamental
- Price
- FULT $19.10
- CRNX $30.00
- Analyst Decision
- FULT Hold
- CRNX Strong Buy
- Analyst Count
- FULT 4
- CRNX 10
- Target Price
- FULT $19.00
- CRNX $75.00
- AVG Volume (30 Days)
- FULT 1.4M
- CRNX 641.2K
- Earning Date
- FULT 07-15-2025
- CRNX 08-07-2025
- Dividend Yield
- FULT 3.77%
- CRNX N/A
- EPS Growth
- FULT 5.42
- CRNX N/A
- EPS
- FULT 1.70
- CRNX N/A
- Revenue
- FULT $1,199,059,000.00
- CRNX $760,000.00
- Revenue This Year
- FULT N/A
- CRNX $402.12
- Revenue Next Year
- FULT $4.31
- CRNX $770.88
- P/E Ratio
- FULT $11.25
- CRNX N/A
- Revenue Growth
- FULT 15.48
- CRNX N/A
- 52 Week Low
- FULT $14.33
- CRNX $24.10
- 52 Week High
- FULT $22.49
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FULT 70.16
- CRNX 44.17
- Support Level
- FULT $17.74
- CRNX $28.34
- Resistance Level
- FULT $18.45
- CRNX $30.01
- Average True Range (ATR)
- FULT 0.46
- CRNX 1.07
- MACD
- FULT 0.17
- CRNX -0.17
- Stochastic Oscillator
- FULT 99.13
- CRNX 36.41
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.